Revolutionising Epilepsy Diagnosis: How Machine Learning Enhances EEG Accuracy
Time to read: 02:56. Researchers have developed EpiScalp, a machine-learning model trained on dynamic network models to identify hidden seizure markers from a single routine EEG. The tool utilizes spectral and network-derived EEG features to differentiate between epilepsy and non-epilepsy a.
Source: Annals of Neurology
Feature
Text
Apixaban vs. Aspirin for Preventing Covert Infarcts in Cryptogenic Stroke: Insights from the ARCADIA-MRI Study
Time to read: 03:16. This study assessed whether apixaban is superior to aspirin in preventing nonlacunar covert infarcts in patients with a recent cryptogenic stroke and atrial cardiopathy.
Source: JAMA Neurology
Text
Exenatide Once a Week Shows Promise as a Disease-Modifying Treatment for Parkinson's Disease
Time to read: 02:15. To determine whether electronic sepsis screening, compared with no screening, reduces 90-day in-hospital mortality among patients admitted to hospital wards.
Source: Lancet
Text
Frailty as a Key Predictor of Dementia: An Accessible Biomarker
Time to read: The purpose of this study was to clarify the temporal relationship between frailty and incident dementia by investigating frailty trajectories in the years leading up to dementia onset. The aim was to identify whether frailty can serve as an early indicator for dementia risk.
Source: JAMA Neurology
Text
10 Years On: Menopausal Hormone Therapy Shows No Cognitive Harm and Mood Benefits in Early Postmenopausal Women
Time to read: 03:49. Specifically, the authors hypothesized that women randomized to transdermal estradiol (tE2) during early post-menopause would show cognitive benefits, while those randomized to oral conjugated equine estrogens (oCEE) would show no effect, compared to placebo over the 10 years following randomization in the Kronos Early Estrogen Prevention Study (KEEPS) trial.
Source: PoLS Medicine
Text
Results from OPTIMAS trial which investigated optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation
Time to read: 03:07. We review the results of the OPTIMAS trial evaluated the safety and efficacy of early DOAC anticoagulation in atrial fibrillation patients with acute ischaemic stroke.
Source: The Lancet
Text
Exploratory Study shows possible link between severe Menopausal symptoms and cognitive impairment
Time to read: 01:35. This study explored the relationship between menopausal symptoms and cognitive decline in postmenopausal women through a sub-analysis of a larger observational study.
Source: Menopause
Text
High-dose Vitamin D3 significantly reduces disease activity in early Multiple Sclerosis: New trial findings
Time to read: 01:33. In a recent randomized, double-blind trial presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024, high-dose oral vitamin D3 (cholecalciferol) supplementation demonstrated significant benefits for patients with clinically isolated syndrome (CIS), a precursor to multiple sclerosis (MS).
Source: ECTRIMS
Text
Cognitive Motor Dissociation in Disorders of Consciousness
Time to read: 01:43. Patients with brain injuries who do not respond to commands may still exhibit cognitive activity detectable through functional magnetic resonance imaging (fMRI) and electroencephalography (EEG).
Source: Neurology
Text
Trial of Botulinum Toxin for Isolated or Essential Head Tremor
Time to read:. 01:01. While beta-blockers effectively treat limb tremors, head tremors pose challenges, botulinum toxin use for head tremor hold promise
Source: New England Journal of Medicine
Text
Genetically proxied lean mass and risk of Alzheimer’s disease: mendelian randomisation study:
Time to read: 01:54. Researchers of this mendeline randomisation study set out to examine whether there is an association between lean mass (genetically proxied) and an increase risk of Alzheimer’s disease.
Source: BMJ Medicine
Text
